Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep

No hay miniatura disponible
Ortiz, P
Scarcella, S
Cerna, C
Rosales, C
Cabrera, M
Guzman, M
Lamenza, P
Solana, H
Título de la revista
Revista ISSN
Título del volumen
Elsevier B.V.
Proyectos de investigación
Unidades organizativas
Número de la revista
Fasciolosis caused by Fasciola hepatica, is the most prevalent parasitic disease in dairy cattle from the northern region of Cajamarca, Peru. The control of this parasite is based on the use of Triclabendazole (TCBZ), a drug that has been used for more than fifteen years in this area. Recent studies, however, have reported a lack of clinical efficacy after treating dairy cattle. This research was aimed to determine the efficacy of TCBZ in a clinical trial.
The authors acknowledge CONCYTEC from Peru for the financial support.
Palabras clave
Triclabendazole, Fasciola hepatica, Drug resistance, Cajamarca